Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Algamed Therapeutics' primary focus?
- Algamed Therapeutics specializes in developing technologies for treating common vaginal conditions, including dryness, infections, menstrual cramps, and dyspareunia.
- What is Algamed Therapeutics' first product?
- Algamed Therapeutics' first product is Secret de Joie, a natural, hormone-free jelly designed to treat vaginal dryness.
- Who is the target demographic for Secret de Joie?
- Secret de Joie is intended for breast and ovarian cancer survivors who need to avoid hormones, as well as postmenopausal, breastfeeding, diabetic women, and those taking birth control pills.
- When was Algamed Therapeutics founded?
- Algamed Therapeutics was founded in August 2014.
- What is the total amount of funding Algamed Therapeutics has raised?
- Algamed Therapeutics has raised a total of $910,000 USD. For a full financing history, please refer to startupim.
- When did Algamed Therapeutics complete its last funding round and what type was it?
- In September 2021, Algamed Therapeutics completed an Equity crowdfunding round, raising $910,000 USD.
- Which investor participated in Algamed Therapeutics' equity crowdfunding round?
- PipelBiz was an investor in Algamed Therapeutics' equity crowdfunding round in September 2021.
- How many employees does Algamed Therapeutics currently have?
- Algamed Therapeutics currently has between 1 and 10 employees.
- Has Algamed Therapeutics received any grants?
- Algamed Therapeutics has received a grant from the IIA.
- What is Algamed Therapeutics' current product stage?
- Algamed Therapeutics' product, Secret de Joie, is currently released.